Font Size: a A A
Keyword [drug eluting stents]
Result: 41 - 60 | Page: 3 of 7
41. Preparation Of Triamcinolone-Eluting Stent And Application In Biliary Benign Stricture
42. Study On Optimizing Antiplatelet Therapy For Patients Undergoing Coronary Artery Stenting Complicated With High On-treatment Platelet Reactivity
43. Improvement Of Ultrasonic Atomizing Spray Device And Optimization Of Coating Preparation Process For Intravascular Stent Coating Design
44. Study On Optimizing Antiplatelet Therapy For Patients Undergoing Coronary Artery Stenting Complicated With High On-treatment Platelet Reactivity
45. The Mechanism Of Late Stent Thrombosis In Coronary Drug-eluting Stents And The Intervention Effect Of VEGF
46. Paclitaxel Drug Coated Baltoonand Paclitaxel Drug Eluting Stents In The Comparative Effectiveness Of Stent Restenosis Lesions
47. The Retrospectively Analysis Of Eariy Drug-eluting Stent Thrombosis
48. Intravascular Ultrasound Comparison Of Second Generation Drug-eluting Stents Versus First Generation Of Drug-eluting Stents: A Meta-analysis
49. Comparison Of Bypass Surgery And Drug-eluting Stenting In Diabetics With Left Main And/or Multivessel Disease:a Meta-analysis Of Randomized And Nonrandomized Studies
50. Drug-eluting Stents And Bare Metal Stents In Acute ST Segment Elevation Myocardial Infarction, The Application Of Comparative Study
51. Comparison Of The Ptognosis Of Three Treatment Strategies In Patients With Multivessel Coronary Artery Disease
52. Comparison Of Effects Of Three Domestic Rapamycin Drug-eluting Stents On Serum SPLA2and Hs-CRP Levels
53. Risk Factors Analysis And Treatment Strategy Of Late And Very Late In-Stent Thrombosis In Patients After Drug-Eluting Stents Implantation Through Optical Coherence Tomography
54. Optimal Duration Of Dual Antiplatelet Therapy In Patients With Acute Coronary Syndromes Undergoing Drug-eluting Stent Implantation: A Meta-analysis
55. Different Duration Of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-eluting Stents In Coronary Disease: A Systematic Review
56. Comparative Study Of Using Biodegradable Polymer Drug Eluting Stents And Durable Polymer Drug Eluting Stents In The Treatment Of Coronary Artery Disease With Multiple Risk Factors
57. Influce Of Ischemic Preconditioning On Neointimal Coverage After Drug-eluting Stents Implantation
58. Safety And Efficacy Of Biodegradable Vs. Permanent Polymer Drug Eluting Stents In Coronary Heart Disease
59. Effect Of A Novel Stent On Re-Endothelialization, Platelet Adhesion And Neointimal Formation
60. The Long- Term Safety And Efficacy Of Endeavor Resolute Stents And Domestic Sirolimus Eluting Stents In The Treatment Of Coronary Heart Disease
  <<First  <Prev  Next>  Last>>  Jump to